Torii Pharmaceutical Co Ltd
TSE:4551

Watchlist Manager
Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd
TSE:4551
Watchlist
Price: 4 435 JPY 0.68% Market Closed
Market Cap: 127.7B JPY
Have any thoughts about
Torii Pharmaceutical Co Ltd?
Write Note

Torii Pharmaceutical Co Ltd
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Torii Pharmaceutical Co Ltd
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
Torii Pharmaceutical Co Ltd
TSE:4551
Intangible Assets
ÂĄ346m
CAGR 3-Years
-13%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
Takeda Pharmaceutical Co Ltd
TSE:4502
Intangible Assets
ÂĄ3.8T
CAGR 3-Years
0%
CAGR 5-Years
-3%
CAGR 10-Years
13%
Daiichi Sankyo Co Ltd
TSE:4568
Intangible Assets
ÂĄ207.8B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
1%
Otsuka Holdings Co Ltd
TSE:4578
Intangible Assets
ÂĄ378.6B
CAGR 3-Years
-10%
CAGR 5-Years
-4%
CAGR 10-Years
13%
Chugai Pharmaceutical Co Ltd
TSE:4519
Intangible Assets
ÂĄ19.6B
CAGR 3-Years
-8%
CAGR 5-Years
-3%
CAGR 10-Years
6%
Astellas Pharma Inc
TSE:4503
Intangible Assets
ÂĄ1.3T
CAGR 3-Years
27%
CAGR 5-Years
25%
CAGR 10-Years
17%
No Stocks Found

Torii Pharmaceutical Co Ltd
Glance View

Market Cap
124.7B JPY
Industry
Pharmaceuticals

Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

Intrinsic Value
3 292.36 JPY
Overvaluation 26%
Intrinsic Value
Price

See Also

What is Torii Pharmaceutical Co Ltd's Intangible Assets?
Intangible Assets
346m JPY

Based on the financial report for Sep 30, 2024, Torii Pharmaceutical Co Ltd's Intangible Assets amounts to 346m JPY.

What is Torii Pharmaceutical Co Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
-7%

Over the last year, the Intangible Assets growth was -21%. The average annual Intangible Assets growth rates for Torii Pharmaceutical Co Ltd have been -13% over the past three years , -8% over the past five years , and -7% over the past ten years .

Back to Top